Vimarsana
Biggest News Aggregation in the World

Robert Mulroy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Mulroy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Mulroy Today - Breaking & Trending Today

Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Vimarsana News

Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Treatment will be Marketed by Nobelpharma Co. Ltd. Under the Trade Name Sargmalin®

Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Vimarsana News

Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

/PRNewswire/ -- Partner Therapeutics, Inc. (PTx) announced that its partner Nobelpharma received approval from the Japanese Pharmaceuticals and Medical Device...

MACK Stock Price | Merrimack Pharmaceuticals Inc. Stock Quote (U.S.: Nasdaq) - Vimarsana News

MACK Stock Price | Merrimack Pharmaceuticals Inc. Stock Quote (U.S.: Nasdaq)

MACK | Complete Merrimack Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.